Advancements and Projections in the Global Blood Recovery Machine Market: Insights, Trends, Opportunities, and Recent ...

Needham analyst Michael Matson has maintained their bullish stance on LIVN stock, giving a Buy rating on October 31. Michael Matson has given ...

Device suitable for use in Cardiac Surgery and Emergency, as an efficient device for collection of blood and autologous autotransfusion.

In the developed world, most of the reported complications of transfusion have an immunological basis. Although the media and the public are worried about the infectious risks of transfusion ...

From January 1995 to August 1995, we prospectively studied 143 consecutive patients having primary total knee or total hip arthroplasty. This study protocol was reviewed and approved by our ...

LivaNova (NASDAQ:LIVN – Get Free Report) is scheduled to announce its earnings results before the market opens on Wednesday, October 30th. Analysts expect the company to announce earnings of $0.71 per ...

matériel d'autotransfusion, dispositifs d'ablation cardiaque, etc. ; - technologies crâniennes et rachidiennes (14,7%) : prothèses rachidiennes, prothèses discales, systèmes de stimulation ...

Autotransfusion, EPO, corticoïdes, hormones de croissance : un cocktail important qu'ont emmagasinés les sujets. Les résultats de l’expérience apparaissent aussi en dehors de la vie sportive ...